Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Advances in mass spectrometry driven O-glycoproteomics.

Levery SB, Steentoft C, Halim A, Narimatsu Y, Clausen H, Vakhrushev SY.

Biochim Biophys Acta. 2015 Jan;1850(1):33-42. doi: 10.1016/j.bbagen.2014.09.026. Epub 2014 Oct 2. Review.

PMID:
25284204
2.

Implications for the offspring of circulating factors involved in beta cell adaptation in pregnancy.

Nalla A, Ringholm L, Søstrup B, Højrup P, Thim L, Levery SB, Vakhrushev SY, Billestrup N, Mathiesen ER, Damm P, Nielsen JH.

Acta Obstet Gynecol Scand. 2014 Nov;93(11):1181-9. doi: 10.1111/aogs.12505. Epub 2014 Oct 16.

PMID:
25223212
3.

Osteoblastic response to pectin nanocoating on titanium surfaces.

Gurzawska K, Svava R, Yihua Y, Haugshøj KB, Dirscherl K, Levery SB, Byg I, Damager I, Nielsen MW, Jørgensen B, Jørgensen NR, Gotfredsen K.

Mater Sci Eng C Mater Biol Appl. 2014 Oct;43:117-25. doi: 10.1016/j.msec.2014.06.028. Epub 2014 Jul 7.

PMID:
25175196
4.

Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.

Kong Y, Joshi HJ, Schjoldager KT, Madsen TD, Gerken TA, Vester-Christensen MB, Wandall HH, Bennett EP, Levery SB, Vakhrushev SY, Clausen H.

Glycobiology. 2015 Jan;25(1):55-65. doi: 10.1093/glycob/cwu089. Epub 2014 Aug 25.

5.

The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy.

Yang Z, Halim A, Narimatsu Y, Jitendra Joshi H, Steentoft C, Schjoldager KT, Alder Schulz M, Sealover NR, Kayser KJ, Paul Bennett E, Levery SB, Vakhrushev SY, Clausen H.

Mol Cell Proteomics. 2014 Dec;13(12):3224-35. doi: 10.1074/mcp.M114.041541. Epub 2014 Aug 4.

6.

Characterization of binding epitopes of CA125 monoclonal antibodies.

Marcos-Silva L, Narimatsu Y, Halim A, Campos D, Yang Z, Tarp MA, Pereira PJ, Mandel U, Bennett EP, Vakhrushev SY, Levery SB, David L, Clausen H.

J Proteome Res. 2014 Jul 3;13(7):3349-59. doi: 10.1021/pr500215g. Epub 2014 Jun 4.

PMID:
24850311
7.

Low density lipoprotein receptor class A repeats are O-glycosylated in linker regions.

Pedersen NB, Wang S, Narimatsu Y, Yang Z, Halim A, Schjoldager KT, Madsen TD, Seidah NG, Bennett EP, Levery SB, Clausen H.

J Biol Chem. 2014 Jun 20;289(25):17312-24. doi: 10.1074/jbc.M113.545053. Epub 2014 May 5.

8.

Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins.

Vester-Christensen MB, Halim A, Joshi HJ, Steentoft C, Bennett EP, Levery SB, Vakhrushev SY, Clausen H.

Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):21018-23. doi: 10.1073/pnas.1313446110. Epub 2013 Oct 7.

9.

The structurally effect of surface coated rhamnogalacturonan I on response of the osteoblast-like cell line SaOS-2.

Svava R, Gurzawska K, Yihau Y, Haugshøj KB, Dirscherl K, Levery SB, Jørgensen NR, Gotfredsen K, Damager I, Ulvskov P, Jørgensen B.

J Biomed Mater Res A. 2014 Jun;102(6):1961-71. doi: 10.1002/jbm.a.34868. Epub 2013 Jul 30.

PMID:
23852647
10.

Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.

Steentoft C, Vakhrushev SY, Joshi HJ, Kong Y, Vester-Christensen MB, Schjoldager KT, Lavrsen K, Dabelsteen S, Pedersen NB, Marcos-Silva L, Gupta R, Bennett EP, Mandel U, Brunak S, Wandall HH, Levery SB, Clausen H.

EMBO J. 2013 May 15;32(10):1478-88. doi: 10.1038/emboj.2013.79. Epub 2013 Apr 12.

11.

Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells.

Liang YJ, Ding Y, Levery SB, Lobaton M, Handa K, Hakomori SI.

Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):4968-73. doi: 10.1073/pnas.1302825110. Epub 2013 Mar 11.

12.

Enhanced mass spectrometric mapping of the human GalNAc-type O-glycoproteome with SimpleCells.

Vakhrushev SY, Steentoft C, Vester-Christensen MB, Bennett EP, Clausen H, Levery SB.

Mol Cell Proteomics. 2013 Apr;12(4):932-44. doi: 10.1074/mcp.O112.021972. Epub 2013 Feb 11.

13.

Glycoproteomic analysis of serum from patients with gastric precancerous lesions.

Gomes C, Almeida A, Ferreira JA, Silva L, Santos-Sousa H, Pinto-de-Sousa J, Santos LL, Amado F, Schwientek T, Levery SB, Mandel U, Clausen H, David L, Reis CA, Osório H.

J Proteome Res. 2013 Mar 1;12(3):1454-66. doi: 10.1021/pr301112x. Epub 2013 Jan 31.

PMID:
23312025
14.

Toward stable genetic engineering of human O-glycosylation in plants.

Yang Z, Bennett EP, Jørgensen B, Drew DP, Arigi E, Mandel U, Ulvskov P, Levery SB, Clausen H, Petersen BL.

Plant Physiol. 2012 Sep;160(1):450-63. doi: 10.1104/pp.112.198200. Epub 2012 Jul 12.

15.

Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells.

Schjoldager KT, Vakhrushev SY, Kong Y, Steentoft C, Nudelman AS, Pedersen NB, Wandall HH, Mandel U, Bennett EP, Levery SB, Clausen H.

Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9893-8. doi: 10.1073/pnas.1203563109. Epub 2012 May 7.

16.

Engineering mammalian mucin-type O-glycosylation in plants.

Yang Z, Drew DP, Jørgensen B, Mandel U, Bach SS, Ulvskov P, Levery SB, Bennett EP, Clausen H, Petersen BL.

J Biol Chem. 2012 Apr 6;287(15):11911-23. doi: 10.1074/jbc.M111.312918. Epub 2012 Feb 14.

17.

Design of a covalently bonded glycosphingolipid microarray.

Arigi E, Blixt O, Buschard K, Clausen H, Levery SB.

Glycoconj J. 2012 Jan;29(1):1-12. doi: 10.1007/s10719-011-9359-9. Epub 2011 Nov 22.

PMID:
22102144
18.

Elucidation of the sugar recognition ability of the lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 by using unnatural glycopeptide substrates.

Yoshimura Y, Nudelman AS, Levery SB, Wandall HH, Bennett EP, Hindsgaul O, Clausen H, Nishimura S.

Glycobiology. 2012 Mar;22(3):429-38. doi: 10.1093/glycob/cwr159. Epub 2011 Oct 31.

PMID:
22042768
19.

Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines.

Steentoft C, Vakhrushev SY, Vester-Christensen MB, Schjoldager KT, Kong Y, Bennett EP, Mandel U, Wandall H, Levery SB, Clausen H.

Nat Methods. 2011 Oct 9;8(11):977-82. doi: 10.1038/nmeth.1731.

PMID:
21983924
20.

A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing.

Schjoldager KT, Vester-Christensen MB, Goth CK, Petersen TN, Brunak S, Bennett EP, Levery SB, Clausen H.

J Biol Chem. 2011 Nov 18;286(46):40122-32. doi: 10.1074/jbc.M111.287912. Epub 2011 Sep 20.

21.

Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity.

Pedersen JW, Bennett EP, Schjoldager KT, Meldal M, Holmér AP, Blixt O, Cló E, Levery SB, Clausen H, Wandall HH.

J Biol Chem. 2011 Sep 16;286(37):32684-96. doi: 10.1074/jbc.M111.273722. Epub 2011 Jul 15.

22.

Immunologic mapping of glycomes: implications for cancer diagnosis and therapy.

Zhou D, Levery SB, Hsu FF, Wang PG, Teneberg S, Almeida IC, Li Y, Xu H, Wang LX, Xia C, Ibrahim NK, Michael K.

Front Biosci (Schol Ed). 2011 Jun 1;3:1520-32. Review.

23.
24.

Random glycopeptide bead libraries for seromic biomarker discovery.

Kracun SK, Cló E, Clausen H, Levery SB, Jensen KJ, Blixt O.

J Proteome Res. 2010 Dec 3;9(12):6705-14. doi: 10.1021/pr1008477. Epub 2010 Nov 2.

25.

O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids.

Schjoldager KT, Vester-Christensen MB, Bennett EP, Levery SB, Schwientek T, Yin W, Blixt O, Clausen H.

J Biol Chem. 2010 Nov 19;285(47):36293-303. doi: 10.1074/jbc.M110.156950. Epub 2010 Sep 13.

26.

N-glycosylation increases the circulatory half-life of human growth hormone.

Flintegaard TV, Thygesen P, Rahbek-Nielsen H, Levery SB, Kristensen C, Clausen H, Bolt G.

Endocrinology. 2010 Nov;151(11):5326-36. doi: 10.1210/en.2010-0574. Epub 2010 Sep 8.

PMID:
20826563
27.

Characterization of an immunodominant cancer-specific O-glycopeptide epitope in murine podoplanin (OTS8).

Steentoft C, Schjoldager KT, Cló E, Mandel U, Levery SB, Pedersen JW, Jensen K, Blixt O, Clausen H.

Glycoconj J. 2010 Aug;27(6):571-82. doi: 10.1007/s10719-010-9301-6. Epub 2010 Aug 19.

PMID:
20721622
28.

Mass spectrometry of fluorocarbon-labeled glycosphingolipids.

Li Y, Arigi E, Eichert H, Levery SB.

J Mass Spectrom. 2010 May;45(5):504-19. doi: 10.1002/jms.1734.

PMID:
20301184
29.

Novel myelin penta- and hexa-acetyl-galactosyl-ceramides: structural characterization and immunoreactivity in cerebrospinal fluid.

Podbielska M, Dasgupta S, Levery SB, Tourtellotte WW, Annuk H, Moran AP, Hogan EL.

J Lipid Res. 2010 Jun;51(6):1394-406. doi: 10.1194/jlr.M001396. Epub 2010 Feb 12.

30.

A novel xylosylphosphotransferase activity discovered in Cryptococcus neoformans.

Reilly MC, Levery SB, Castle SA, Klutts JS, Doering TL.

J Biol Chem. 2009 Dec 25;284(52):36118-27. doi: 10.1074/jbc.M109.056226. Epub 2009 Oct 28.

31.

Immunologic glycosphingolipidomics and NKT cell development in mouse thymus.

Li Y, Thapa P, Hawke D, Kondo Y, Furukawa K, Furukawa K, Hsu FF, Adlercreutz D, Weadge J, Palcic MM, Wang PG, Levery SB, Zhou D.

J Proteome Res. 2009 Jun;8(6):2740-51. doi: 10.1021/pr801040h.

32.

Stress-induced cell death is mediated by ceramide synthesis in Neurospora crassa.

Plesofsky NS, Levery SB, Castle SA, Brambl R.

Eukaryot Cell. 2008 Dec;7(12):2147-59. doi: 10.1128/EC.00147-08. Epub 2008 Oct 24.

33.

Response to Milland et al.: Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies.

Zhou D, Levery SB.

Immunol Cell Biol. 2008 Nov-Dec;86(8):631-2; author reply 633-4. doi: 10.1038/icb.2008.65. Epub 2008 Sep 9. No abstract available.

PMID:
18779838
34.

Beta1,2-xylosyltransferase Cxt1p is solely responsible for xylose incorporation into Cryptococcus neoformans glycosphingolipids.

Castle SA, Owuor EA, Thompson SH, Garnsey MR, Klutts JS, Doering TL, Levery SB.

Eukaryot Cell. 2008 Sep;7(9):1611-5. doi: 10.1128/EC.00458-07. Epub 2008 Aug 1.

35.

Identification of a GH110 subfamily of alpha 1,3-galactosidases: novel enzymes for removal of the alpha 3Gal xenotransplantation antigen.

Liu QP, Yuan H, Bennett EP, Levery SB, Nudelman E, Spence J, Pietz G, Saunders K, White T, Olsson ML, Henrissat B, Sulzenbacher G, Clausen H.

J Biol Chem. 2008 Mar 28;283(13):8545-54. doi: 10.1074/jbc.M709020200. Epub 2008 Jan 28.

36.

Sensitive detection of isoglobo and globo series tetraglycosylceramides in human thymus by ion trap mass spectrometry.

Li Y, Teneberg S, Thapa P, Bendelac A, Levery SB, Zhou D.

Glycobiology. 2008 Feb;18(2):158-65. Epub 2007 Dec 3. Erratum in: Glycobiology. 2008 Aug;18(8):568.

PMID:
18056651
37.

Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry.

Li Y, Zhou D, Xia C, Wang PG, Levery SB.

Glycobiology. 2008 Feb;18(2):166-76. Epub 2007 Nov 28.

PMID:
18048405
38.

Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies.

Suzuki E, Tanaka AK, Toledo MS, Levery SB, Straus AH, Takahashi HK.

Biochim Biophys Acta. 2008 Mar;1780(3):362-9. Epub 2007 Sep 25. Review.

PMID:
17976917
39.

Glycosphingolipids with extended sugar chain have specialized functions in development and behavior of Drosophila.

Chen YW, Pedersen JW, Wandall HH, Levery SB, Pizette S, Clausen H, Cohen SM.

Dev Biol. 2007 Jun 15;306(2):736-49. Epub 2007 Apr 18.

40.

Analysis of glycosylinositol phosphorylceramides expressed by the opportunistic mycopathogen Aspergillus fumigatus.

Toledo MS, Levery SB, Bennion B, Guimaraes LL, Castle SA, Lindsey R, Momany M, Park C, Straus AH, Takahashi HK.

J Lipid Res. 2007 Aug;48(8):1801-24. Epub 2007 May 8.

41.

A beta-1,2-xylosyltransferase from Cryptococcus neoformans defines a new family of glycosyltransferases.

Klutts JS, Levery SB, Doering TL.

J Biol Chem. 2007 Jun 15;282(24):17890-9. Epub 2007 Apr 12.

42.

Bacterial glycosidases for the production of universal red blood cells.

Liu QP, Sulzenbacher G, Yuan H, Bennett EP, Pietz G, Saunders K, Spence J, Nudelman E, Levery SB, White T, Neveu JM, Lane WS, Bourne Y, Olsson ML, Henrissat B, Clausen H.

Nat Biotechnol. 2007 Apr;25(4):454-64. Epub 2007 Apr 1.

PMID:
17401360
43.

Characterization of neutral and acidic glycosphingolipids from the lectin-producing mushroom, Polyporus squamosus.

Arigi E, Singh S, Kahlili AH, Winter HC, Goldstein IJ, Levery SB.

Glycobiology. 2007 Jul;17(7):754-66. Epub 2007 Mar 29.

PMID:
17395693
44.
45.

Glycosphingolipid structural analysis and glycosphingolipidomics.

Levery SB.

Methods Enzymol. 2005;405:300-69. Review.

PMID:
16413319
46.

Structure elucidation of neutral, di-, tri-, and tetraglycosylceramides from High Five cells: identification of a novel (non-arthro-series) glycosphingolipid pathway.

Fuller MD, Schwientek T, Wandall HH, Pedersen JW, Clausen H, Levery SB.

Glycobiology. 2005 Dec;15(12):1286-301. Epub 2005 Jul 13.

PMID:
16014747
47.

Neutral glycolipids of the filamentous fungus Neurospora crassa: altered expression in plant defensin-resistant mutants.

Park C, Bennion B, François IE, Ferket KK, Cammue BP, Thevissen K, Levery SB.

J Lipid Res. 2005 Apr;46(4):759-68. Epub 2005 Jan 16.

48.

Egghead and brainiac are essential for glycosphingolipid biosynthesis in vivo.

Wandall HH, Pizette S, Pedersen JW, Eichert H, Levery SB, Mandel U, Cohen SM, Clausen H.

J Biol Chem. 2005 Feb 11;280(6):4858-63. Epub 2004 Dec 15.

49.

Lysosomal glycosphingolipid recognition by NKT cells.

Zhou D, Mattner J, Cantu C 3rd, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T, Teneberg S, Wang D, Proia RL, Levery SB, Savage PB, Teyton L, Bendelac A.

Science. 2004 Dec 3;306(5702):1786-9. Epub 2004 Nov 11.

50.

UDP-glucose dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans.

Griffith CL, Klutts JS, Zhang L, Levery SB, Doering TL.

J Biol Chem. 2004 Dec 3;279(49):51669-76. Epub 2004 Sep 21.

Supplemental Content

Loading ...
Support Center